Many studies have indicated that higher levels of BCRP expression were associated with lower survival rates of AML, and increased expression of BCRP in patients is observed in patients that fail to achieve CR after chemotherapy (82, 88, 89). Here, ABCG2 is linked to acute myeloid leukemia.